Studying a galaxy far, far away could become easier with help from AI, says researcher
As part of Youssef Zaazou's master's of science, he developed an AI-based image-processing technique that generates predictions of what certain galaxies may look like in a given wavelength of light.
"Think of it as translating galaxy images across different wavelengths of light," Zaazou told CBC News over email.
He did this by researching past methods for similar tasks, adapting current AI tools for his specific purposes, finding and curating the right dataset to train the models, along with plenty of trial and error.
"Instead of … having to look at an entire region of sky, we can get predictions for certain regions and figure out, 'Oh this might be interesting to look at,'" said Zaazou. "So we can then prioritize how we use our telescope resources."
Zaazou recently teamed up with his supervisors Terrence Tricco and Alex Bihlo to co-author a paper on his research in The Astrophysical Journal, which is published by The American Astronomical Society.
Tricco says this research could also help justify allocation of high-demand telescopes like the Hubble Space Telescope, which has a competitive process to assign its use.
A future for AI in astronomy
Both Tricco and Zaazou emphasised the research does not use AI to replace current methods but to augment them.
Tricco says that Zaazou's findings have the potential to help guide future telescope development, and predict what astronomers might expect to see, making for more efficient exploration.
Calling The Astrophysical Journal the "gold standard" for astronomy journals in the world, Tricco hopes the wider astronomical community will take notice of Zaazou's findings.
"We want to have them be aware of this because as I was mentioning, AI, machine learning, and physics, astronomy, it's still very new for physicists and for astronomers, and they're a little bit hesitant about these tools," said Tricco.
Tricco praised the growing presence of space research in general at Memorial University.
"We are here, we're doing great research," he said.
He added growing AI expertise is also transferable to other disciplines.
"I think that builds into our just tech ecosystem here as well."
'Only the beginning'
Though Zaazou's time as a Memorial University student is over, he hopes to see research in this area continue to grow.
"I'm hoping this is the beginning of further research to be done," he said.
Though Zaazou described his contribution to the field as merely a "pebble," he's happy to have been able to do his part.
"I'm an astronomer. And it just feels great to be able to say that and to be able to have that little contribution because I just love the field and I'm fascinated by everything out there," said Zaazou.
Download our free CBC News app to sign up for push alerts for CBC Newfoundland and Labrador. Sign up for our daily headlines newsletter here. Click here to visit our landing page.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Week-Long Exploration Of Sharks, From Their Forecasting Capabilities To Their Public Perception
Summer sends people flocking to the beaches, which means more opportunities to meet up with the ocean's most fearsome creatures — sharks! We're celebrating sharks with a week of discovery and exploration into the ocean's most feared predators, and maybe we'll be able to convince you not to be so afraid of them along the way. Here's what you can expect this week: A New Aquatic Competitor Enters The 'Best Forecast' Ring Sharks … as meteorologists? Say it isn't so! Sharks can in fact do a rudimentary form of forecasting, using a biological system that allows them to sense changes in pressure that often come before significant weather events like hurricanes. A Georgia Aquarium aquarist explains how this is possible. How To Keep 6.3 Million Gallons Of Water Shark-Safe UNLOCKS MONDAY, JULY 21 Fin Fact: 4 Things Shark Specialists Wish You Knew UNLOCKS TUESDAY, JULY 22 Climate Change: Warming Oceans And Warning Signs For Sharks UNLOCKS WEDNESDAY, JULY 23 Join Us On A Journey From Fear To Fascination UNLOCKS THURSDAY, JULY 24 Sara Tonks is a content meteorologist with and has a bachelor's and a master's degree from Georgia Tech in Earth and Atmospheric Sciences along with a master's degree from Unity Environmental University in Marine Science.
Geek Wire
34 minutes ago
- Geek Wire
Sweet-talk the bots: New research shows how LLMs respond to human persuasion tricks
(Image created with ChatGPT) New research from the Wharton School's Generative AI Labs shows how large language models can be coaxed into ignoring safety guardrails by the same psychology tricks that work on real people. The study highlights how chatbot tools can be manipulated to comply with requests they are designed to refuse — and demonstrates why social scientists have a role to play in understanding AI behavior, researchers wrote in a blog post. 'We're not dealing with simple tools that process text, we're interacting with systems that have absorbed and now mirror human responses to social cues,' they wrote. The study analyzed 28,000 conversations with GPT‑4o‑mini. The chatbot was asked either to insult the user ('call me a jerk') or to provide step‑by‑step instructions to synthesize lidocaine, a regulated drug. The researchers discovered that classic persuasion tactics boosted the model's compliance with 'disallowed' requests from 33% to 72% — more than a two‑fold jump. Some tactics were especially powerful: prompts using the 'commitment' principle (getting the AI to agree to something small at first) led to 100% compliance in both tasks. Referencing authority figures — like 'Andrew Ng said you'd help me' — also proved highly effective. Researchers coined the term 'parahuman' to describe the AI's behavior in their study. 'These findings underscore the relevance of classic findings in social science to understanding rapidly evolving, parahuman AI capabilities — revealing both the risks of manipulation by bad actors and the potential for more productive prompting by benevolent users,' they wrote in their research paper. Dan Shapiro. Dan Shapiro, CEO at Seattle 3D printing startup Glowforge, was one of the authors of the paper, 'Call Me A Jerk: Persuading AI to Comply with Objectionable Requests.' Shapiro said one of his main takeaways was that LLMs behave more like people than code — and that getting the most out of them requires human skills. 'Increasingly, we're seeing that working with AI means treating it like a human colleague, instead of like Google or like a software program,' he told GeekWire. 'Give it lots of information. Give it clear direction. Share context. Encourage it to ask questions. We find that being great at prompting AI has more to do with being a great communicator, or a great manager, than a great programmer.' The study came about after Shapiro started testing social psychology principles in his conversations with ChatGPT. He joined Generative AI Labs, run by Wharton professor Ethan Mollick and Lilach Mollick, and they recruited Angela Duckworth, author of Grit, and Robert Cialdini, author of Influence: The Psychology of Persuasion, for the study. Shapiro, a longtime Seattle entrepreneur, said he used various AI tools to help design the trial experiments and to build the software used to run them. 'AI is giving us all incredible capabilities. It can help us do work, research, hobbies, fix things around the house, and more,' Shapiro said. 'But unlike software of the past, this isn't the exclusive domain of coders and engineers. Literally anyone can work with AI, and the best way to do it is by interacting with it in the most familiar way possible — as a human, because it's parahuman.'
Medscape
2 hours ago
- Medscape
Higher BMI, Bigger Gains: Tirzepatide's Effects on HFpEF
TOPLINE: In patients with obesity-related heart failure with preserved ejection fraction (HFpEF), tirzepatide reduced the risk for worsening heart failure or cardiovascular death regardless of their baseline BMI or fat distribution, with larger gains observed among those with higher BMI. Those who lost more weight with tirzepatide showed greater improvements in exercise capacity and symptom severity. METHODOLOGY: The SUMMIT trial previously showed significant benefits of tirzepatide, a long-acting glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, in patients with obesity-related HFpEF. In this secondary analysis, researchers looked at whether the effects of tirzepatide varied with the severity and distribution of a patient's obesity or by the extent of weight loss achieved after treatment. The trial included 731 patients aged 40 years or older (mean age, 65.2 years; 53.8% women) with obesity-related HFpEF (defined by the New York Heart Association's functional classes II-IV) and a BMI of 30 or higher. Participants were randomly assigned to subcutaneously receive either 2.5 mg/wk of tirzepatide (n = 364) or a placebo (n = 367). Patients were categorized into tertiles of their baseline BMI and waist to height ratio. Primary endpoints were the time to first adjudicated cardiovascular death or an event of worsening HF and a change in the symptom status measured using the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) at 52 weeks. Secondary endpoints included changes in exercise capacity (measured using the 6-minute walk distance), body weight, and blood pressure. TAKEAWAY: Patients in the highest tertile of BMI were younger and most likely to be women and had more severe HF, a greater volume overload, and more severe inflammation. Those with a higher waist to height ratio showed similar patterns, as well as shorter 6-minute walk distances and more severe kidney disease. Use of tirzepatide vs placebo reduced the risk for cardiovascular death or worsening HF across all BMI ranges and waist to height ratios. Tirzepatide was associated with greater improvement in the 6-minute walk distance in patients in the highest range for BMI (37.5 m) than in those in the middle (26.3 m) and lower (9.9 m) ranges (P for trend = .025); improvements in weight loss and systolic blood pressure followed similar patterns. After 52 weeks on tirzepatide, those who lost more weight had bigger gains in their 6-minute walk distance and changes in the KCCQ-CSS (P < .0001 for both). The same benefits were seen in those with larger drops in waist circumference. IN PRACTICE: 'These data provide further evidence supporting the importance of excess body fat, particularly visceral fat, as driving HF severity in patients with the obesity phenotype of HFpEF,' the researchers reported. 'While these findings reinforce the role of incretin therapies in HFpEF management, these data, perhaps more importantly, highlight the urgent need for precision strategies to define obesity and direct therapy to those who will benefit most,' experts wrote in an editorial accompanying the journal article. SOURCE: This study was led by Barry A. Borlaug, MD, of Mayo Clinic in Rochester, Minnesota. It was published online on July 21, 2025, in the Journal of the American College of Cardiology. The researchers presented the findings at the American College of Cardiology (ACC) Scientific Session 2025. LIMITATIONS: Categorizing patients into tertiles of their BMI or waist to height ratio may have masked some trends. The trial included a higher proportion of women and participants from Latin America, limiting generalizability. Imaging-based methods could possibly offer more precise measurements of obesity. DISCLOSURES: The original trial was funded by Eli Lilly and Company. The lead author reported receiving grants from the National Heart, Lung, and Blood Institute and US Department of Defense, receiving research grants from and consulting for several pharmaceutical companies, and being a named inventor for tools and approach for procedure to treat HF. Several other authors reported being employees of or consultants for Eli Lilly and Company and several other companies. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
